• Nachrichtendetail
• 

31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	Regeneron Pharmaceuticals	881535	NASDAQ	1.071,190	22.07.24 20:42:45	+7,590	+0,71%	1.070,260	1.072,810	1.075,350	1.063,600